These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
886 related items for PubMed ID: 11471361
21. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension. Xu KT, Moloney M, Phillips S. Am J Manag Care; 2003 Aug; 9(8):529-36. PubMed ID: 12921230 [Abstract] [Full Text] [Related]
22. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines. Balu S. Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408 [Abstract] [Full Text] [Related]
23. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service. Marković BB, Kranjcević K, Reiner Z, Blazeković SM, Spehar SS. Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354 [Abstract] [Full Text] [Related]
24. [Differences between management guidelines and global health strategies for arterial hypertension with metabolic disorders in France in 1999. Ohara study]. Mallion JM, Kahn JC, Poncelet P, Pannier B, Vaïsse B, Koch C, Phan TM, Pithois-Merli I. Arch Mal Coeur Vaiss; 2001 Aug; 94(8):834-8. PubMed ID: 11575213 [Abstract] [Full Text] [Related]
25. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden. Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlöv P, Brunkstedt I, Svensson P, Gyllerup S, Sträng B, Persson R, Janzon L. Scand J Prim Health Care; 2006 Dec; 24(4):224-30. PubMed ID: 17118862 [Abstract] [Full Text] [Related]
26. [Application of guidelines concerning systolic hypertension in patients over 80 years of age: experience in a geriatric institute]. Escande M, Diadema B. Arch Mal Coeur Vaiss; 2006 Dec; 99(7-8):742-4. PubMed ID: 17061456 [Abstract] [Full Text] [Related]
27. Blood pressure control of drug treated hypertension in 18 general practices. Aylett M, Creighton P, Jachuck S, Newrick D, Evans A. J Hum Hypertens; 1996 Aug; 10(8):547-50. PubMed ID: 8895039 [Abstract] [Full Text] [Related]
28. Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSYST survey. Van der Niepen P, Giot C, van de Borne P. J Hypertens; 2008 Oct; 26(10):2057-63. PubMed ID: 18806631 [Abstract] [Full Text] [Related]
29. Factors associated with drug adherence and blood pressure control in patients with hypertension. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Pharmacotherapy; 2006 Apr; 26(4):483-92. PubMed ID: 16553506 [Abstract] [Full Text] [Related]
30. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. Zanchetti A, Grassi G, Mancia G. J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107 [Abstract] [Full Text] [Related]
31. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD, Canadian Hypertension Education Program. Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449 [Abstract] [Full Text] [Related]
32. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
33. Cost analysis of different pharmacological treatment strategies in elderly hypertensives. Linjer E, Hedner T, Jönsson B, Ekbom T, Lindholm LH, Dahlöf B, de Faire U, Scherstén B, Stop-2 Hypertension Group. Blood Press; 2005 May; 14(2):107-13. PubMed ID: 16036488 [Abstract] [Full Text] [Related]
34. How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city. Tang JL, Wang WZ, An JG, Hu YH, Cheng SH, Griffiths S. Int J Epidemiol; 2010 Feb; 39(1):244-54. PubMed ID: 19491141 [Abstract] [Full Text] [Related]
35. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus]. Boero R, Prodi E, Borsa S, Berti V, Fiorio E, Ferraro L, Massara C, Quarello F. G Ital Nefrol; 2002 Feb; 19(4):413-8. PubMed ID: 12369043 [Abstract] [Full Text] [Related]
36. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2011 Feb 04; 60(4):103-8. PubMed ID: 21293325 [Abstract] [Full Text] [Related]
37. [Drug prescription and utilization in Morocco]. Simon N, Hakkou F, Minani M, Jasson M, Diquet B. Therapie; 1998 Feb 04; 53(2):113-20. PubMed ID: 9773110 [Abstract] [Full Text] [Related]
38. Actual blood pressure control: are we doing things right? Coca A. J Hypertens Suppl; 1998 Jan 04; 16(1):S45-51. PubMed ID: 9534097 [Abstract] [Full Text] [Related]
39. [Systolic-diastolic arterial hypertension versus isolated systolic hypertension]. Giannuzzi P, Eleuteri E. Ital Heart J; 2000 Jun 04; 1 Suppl 2():93-9. PubMed ID: 10905135 [Abstract] [Full Text] [Related]
40. [Are the 1999 World Health Organization-International Society of Hypertension recommendations applicable to clinical practice?]. Hanon O, Anagnostopoulos K, Franconi G, Amah G, Safar M, Girerd X. Arch Mal Coeur Vaiss; 2000 Aug 04; 93(8):953-7. PubMed ID: 10989736 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]